bf/NASDAQ:BNTX_icon.jpeg

NASDAQ:BNTX

BioNTech SE

  • Stock

USD

Last Close

92.72

06/05 20:00

Market Cap

22.54B

Beta: 0.22

Volume Today

1.09M

Avg: 618.15K

PE Ratio

7.56

PFCF: 4.40

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.57M
-
4.83M
35.33%
8.76M
81.18%
37.92M
333.11%
283.31M
647.11%
471.05M
66.27%
398.65M
15.37%
average payables
29.38M
-
47.13M
60.42%
31.11M
33.99%
61.39M
97.34%
131.14M
113.61%
182.05M
38.82%
279.05M
53.28%
average receivables
7.53M
-
18.77M
149.13%
24.32M
29.60%
93.29M
283.54%
6.27B
6,625.84%
9.76B
55.62%
4.74B
51.43%
book value per share
-0.22
-
1.17
639.91%
2.33
98.88%
5.42
132.11%
48.74
800.03%
82.44
69.12%
84.15
2.07%
capex per share
-0.25
-
-0.30
17.51%
-0.34
12.36%
-0.34
0.37%
-0.63
87.10%
-1.49
136.61%
-2.93
96.36%
capex to depreciation
-5.48
-
-3.09
43.72%
-2.10
32.06%
-2.21
5.17%
-2.05
7.14%
-2.95
43.88%
-3.85
30.56%
capex to operating cash flow
1.10
-
1.17
6.17%
0.36
69.30%
6.34
1,671.29%
-0.17
102.73%
-0.03
84.54%
-0.13
390.86%
capex to revenue
-0.94
-
-0.53
43.26%
-0.65
23.07%
-0.18
72.94%
-0.01
95.42%
-0.02
158.61%
-0.18
780.23%
cash per share
0.76
-
1.82
138.95%
2.46
35.65%
5.32
116.02%
8.50
59.81%
57.81
580.04%
68.78
18.98%
days of inventory on hand
14.92
-
13.48
9.65%
17.55
30.16%
33.23
89.36%
47.51
42.98%
35.40
25.48%
217.67
514.82%
days payables outstanding
202.25
-
97.16
51.96%
30.68
68.42%
53.01
72.74%
15.13
71.46%
16.44
8.67%
215.42
1,210.52%
days sales outstanding
53.89
-
81.37
51.00%
67.92
16.53%
125.90
85.38%
238.16
89.17%
150.68
36.73%
223.62
48.41%
debt to assets
0.08
-
0.19
144.32%
0.09
50.25%
0.10
3.62%
0.10
7.98%
0.02
81.62%
0.01
52.14%
0.01
4.48%
debt to equity
0.97
-
-1.41
245.11%
0.23
116.06%
0.16
31.74%
0.18
12.91%
0.03
85.52%
0.01
58.26%
0.01
2.28%
dividend yield
0.01
-
earnings yield
-0.03
-
-0.02
46.60%
-0.03
64.60%
0.00
103.20%
0.19
20,587.77%
0.28
48.75%
0.04
85.31%
enterprise value
-277.01M
-
2.57B
1,026.44%
2.46B
3.96%
5.95B
141.28%
16.00B
169.01%
54.15B
238.51%
20.56B
62.02%
11.53B
43.94%
enterprise value over ebitda
-52.65
-
-82.13
56.01%
-40.68
50.47%
-379.90
833.79%
3.62
100.95%
1.57
56.59%
9.98
535.42%
ev to operating cash flow
-48.83
-
-42.36
13.24%
-29.95
29.29%
-1.19K
3,863.86%
60.87
105.13%
1.51
97.51%
2.15
41.70%
ev to sales
41.66
-
19.32
53.63%
54.76
183.47%
33.17
39.44%
2.85
91.40%
1.19
58.37%
3.02
154.10%
free cash flow per share
-0.49
-
-0.56
14.26%
-1.27
129.46%
-0.39
69.37%
3.02
872.08%
54.32
1,701.44%
19.39
64.30%
free cash flow yield
-0.04
-
-0.04
8.84%
-0.04
5.63%
-0.01
86.17%
0.01
327.19%
0.39
2,814.68%
0.20
47.39%
graham net net
-1.07
-
0.22
120.71%
1.12
409.19%
2.20
95.85%
31.46
1,329.15%
67.50
114.58%
65.35
3.18%
graham number
1.36
-
2.36
73.98%
6.67
182.13%
2.70
59.45%
215.09
7,854.60%
268.20
24.69%
85.56
68.10%
income quality
0.61
-
1.22
99.50%
1.11
9.36%
0.09
91.65%
0.06
36.02%
1.05
1,672.55%
4.53
332.07%
intangibles to total assets
0.03
-
0.22
677.32%
0.13
39.52%
0.11
16.84%
0.07
37.11%
0.01
81.87%
0.01
26.18%
0.05
437.29%
interest coverage
-90.65
-
-31.29
65.48%
-105.66
237.64%
-1.27
98.80%
2.83K
223,145.39%
668.93
76.37%
89.22
86.66%
interest debt per share
0.31
-
0.27
11.70%
0.37
34.97%
1.20
225.63%
1.26
4.41%
0.95
24.48%
0.94
0.75%
inventory turnover
24.46
-
27.07
10.68%
20.80
23.17%
10.99
47.19%
7.68
30.06%
10.31
34.18%
1.68
83.73%
invested capital
0.97
-
-1.41
245.11%
0.23
116.06%
0.16
31.74%
0.18
12.91%
0.03
85.52%
0.01
58.26%
0.01
2.28%
market cap
2.69B
-
2.82B
4.98%
6.40B
126.69%
16.97B
165.24%
55.54B
227.36%
34.23B
38.38%
22.97B
32.88%
net current asset value
-39.98M
-
-233.28M
483.56%
62.98M
127.00%
256.00M
306.50%
720.12M
181.30%
11.14B
1,446.29%
18.70B
67.92%
16.77B
10.33%
net debt to ebitda
2.50
-
11.91
376.67%
3.08
74.13%
23.04
647.84%
-0.09
100.40%
-1.04
1,022.66%
-9.91
849.45%
net income per share
-0.38
-
-0.21
43.94%
-0.85
300.22%
0.06
107.08%
42.18
70,203.96%
38.78
8.07%
3.87
90.03%
operating cash flow per share
-0.23
-
-0.26
10.69%
-0.94
266.03%
-0.05
94.33%
3.65
6,954.76%
55.81
1,430.58%
22.33
60.00%
payables turnover
1.80
-
3.76
108.16%
11.90
216.65%
6.89
42.11%
24.13
250.41%
22.20
7.98%
1.69
92.37%
receivables turnover
6.77
-
4.49
33.77%
5.37
19.81%
2.90
46.06%
1.53
47.14%
2.42
58.06%
1.63
32.62%
research and ddevelopement to revenue
1.39
-
1.12
19.22%
2.09
86.01%
1.34
35.88%
0.01
99.60%
0.01
23.82%
0.47
6,867.55%
return on tangible assets
-0.29
-
-0.08
71.11%
-0.25
197.64%
0.01
102.79%
0.66
9,238.85%
0.41
37.88%
0.04
89.59%
revenue per share
0.27
-
0.56
107.11%
0.51
8.70%
1.90
270.88%
77.77
3,984.38%
71.16
8.51%
15.87
77.69%
roe
1.74
-
-0.18
110.38%
-0.36
101.24%
0.01
103.05%
0.87
7,711.29%
0.47
45.64%
0.05
90.23%
roic
-3.00
-
-0.17
94.43%
-0.32
90.44%
0.01
101.68%
0.86
15,986.64%
0.45
47.10%
0.03
94.22%
sales general and administrative to revenue
0.37
-
0.19
49.27%
0.37
98.79%
0.19
47.97%
0.01
92.47%
0.03
90.79%
0.13
362.91%
shareholders equity per share
-0.22
-
1.17
639.91%
2.33
98.88%
5.42
132.11%
48.74
800.03%
82.44
69.12%
84.15
2.07%
stock based compensation to revenue
0.10
-
0.06
37.56%
0.28
364.88%
0.07
76.07%
0.00
93.63%
0.01
47.89%
0.01
114.53%
tangible asset value
20.67M
-
-131.74M
737.24%
178.96M
235.84%
404.06M
125.78%
1.21B
199.06%
11.69B
867.54%
19.84B
69.66%
19.08B
3.81%
tangible book value per share
-0.58
-
0.79
235.84%
1.91
142.18%
4.77
149.70%
47.92
904.42%
81.54
70.17%
79.30
2.74%
working capital
261.49M
-
31.09M
88.11%
322.84M
938.30%
422.01M
30.72%
1.06B
151.39%
11.59B
992.55%
18.97B
63.68%
17.46B
7.98%

All numbers in USD (except ratios and percentages)